Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System

NCT: NCT07745244 · RECRUITING

NCT IDNCT07745244
StatusRECRUITING
Start Date2026-06-01
Completion2027-12-01
SponsorSiBionics, Co, Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

The study is to evaluate the accuracy and safety of a real-time CGM system among adult patients with type 1 diabetes with respect to reference venous plasma sample measurements.

Frequently Asked Questions

What is Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System?

Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System is a clinical trial registered under NCT07745244. Current status: RECRUITING.

What is the status of NCT07745244?

The current status of NCT07745244 (Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System) is: RECRUITING.

When did Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System start?

Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System started on 2026-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.